A recent study reveals that patients who come off popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end conventional diet and exercise regimens.
Research printed in a major health publication demonstrates that while overweight people often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month once they quit.
"People buying such treatments must be aware of the potential of quick weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to starting weight in about 18 months.
Weighing Treatments
The research, which reviewed 37 of studies involving thousands of patients, compared the effects of these new drugs with older methods.
Scientists emphasize that people who lose weight through lifestyle changes alone usually see a slower weight regain—around 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists believe the way of the injections accounts for the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating far more likely."
A Chronic Disease?
The NHS advise the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the treatment is often ongoing.
This opinion is reinforced by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," similar to managing conditions like hypertension.
User Testimonies
People who have discontinued the medication explain a intense resurgence of appetite.
"I experienced a trigger activating and you're instantly extremely hungry," described one woman.
The struggle is worsened if users have not adopted sustainable dietary or behavioural modifications during therapy.
Widespread Use
Survey data suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Use is greater among females than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent cure and maintained weight loss likely depends on ongoing lifestyle changes.
